Open access · CC-BY
via OpenAlex
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
Tingting Du, Le Wang, Weijin Liu, Guanyu Zhu, Ying‐Chuan Chen, Jianguo Zhang
Frontiers in Aging Neuroscience · 2021 · ▲ 38 citations
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the presence of α-synuclein (α-Syn)-rich Lewy bodies (LBs) and the preferential loss of dopaminergic (DA) neurons in the substantia nigra (SN) pars compacta (SNpc). However, the widespread involvement of other central nervous systems (CNS) structures and peripheral tissues is now widely documented. The onset of the molecular and cellular neuropathology of PD likely occurs decades before the onset of the motor symptoms characteristic of PD, so early diagnosis of PD and adequate tracking of disease progression could significantly improve outcomes for patients. Because the clinical diagnosis of PD is challenging, misdiagnosis is common, which highlights the need for disease-specific and early-stage biomarkers. This review article aims to summarize useful biomarkers for the diagnosis of PD, as well as the biomarkers used to monitor disease progression. This review article describes the role of α-Syn in PD and how it could potentially be used as a biomarker for PD. Also, preclinical and clinical investigations encompassing genetics, immunology, fluid and tissue, imaging, as well as neurophysiology biomarkers are discussed. Knowledge of the novel biomarkers for preclinical detection and clinical evaluation will contribute to a deeper understanding of the disease mechanism, which should more effectively guide clinical applications.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fnagi.2021.645996
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Du, T., Wang, L., Liu, W., Zhu, G., Chen, Y., & Zhang, J. (2021). Biomarkers and the Role of α-Synuclein in Parkinson’s Disease. <em>Frontiers in Aging Neuroscience</em>. https://doi.org/10.3389/fnagi.2021.645996
Vancouver
Du T, Wang L, Liu W, Zhu G, Chen Y, Zhang J. Biomarkers and the Role of α-Synuclein in Parkinson’s Disease. Frontiers in Aging Neuroscience. 2021. doi:10.3389/fnagi.2021.645996.
BibTeX
@article{tingting2021Biomar,
title = {Biomarkers and the Role of α-Synuclein in Parkinson’s Disease},
author = {Tingting Du and Le Wang and Weijin Liu and Guanyu Zhu and Ying‐Chuan Chen and Jianguo Zhang},
journal = {Frontiers in Aging Neuroscience},
year = {2021},
doi = {10.3389/fnagi.2021.645996},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Cellular Neuroscience 2024
Open access · CC-BY
Circadian rhythm disruption: a potential trigger in Parkinson’s disease pathogenesis
Annual Review of Neuroscience 2021
Open access · OA
Parkinson's Disease Genetics and Pathophysiology
International Journal of Molecular Sciences 2020
Open access · CC-BY
Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
Parkinson s Disease 2016
Open access · CC-BY
Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
Journal of Molecular Neuroscience 2017
Open access · CC-BY
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
BioMed Research International 2015
Open access · CC-BY